Logo for Assertio Holdings Inc

Assertio Investor Relations Material

Latest events

Logo for Assertio Holdings Inc

Q4 2023

Assertio
Logo for Assertio

Investor Presentation

5 Apr, 2024
Logo for Assertio

Q4 2023

11 Mar, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Assertio Holdings Inc

Access all reports
Segment Data
Access more data
Product sales by
Product
INDOCIN products
CAMBIA
Otrexup
SPRIX
Other
Expenses by
Financials
Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital and pain, and inflammation. The Company's neurology products are used to treat central nervous system disorders such as attention deficit hyperactivity disorder (ADHD), Parkinson's disease and epilepsy. Its hospital unit is involved in manufacturing injectable general solutions for parenteral nutrition applications. Its pain and inflammation business develops prescription topical creams that are used to treat various inflammatory joint-pain related symptoms.